Cure Research for Non-Small Cell Lung Cancer

Medications currently used in research into the treatment of Non-Small Cell Lung Cancer:

Note:You must always seek professional medical advice about any treatment or change in treatment plans.

Some of the different medications being used in the research into treatment of Non-Small Cell Lung Cancer include:

• Raltitrexed
• Tomudex
• Topotecan
• Hycamtin

Treatments for Non-Small Cell Lung Cancer

Treatments to consider for Non-Small Cell Lung Cancer may include:

• More than one kind of treatment is often used, depending on the stage of the cancer, the individual's overall health, age, response to chemotherapy, and other factors such as the likely side effects of the treatment. Treatment may include
• Surgery if diagnosed at an early stage, often with adjuvant (anciliary) chemotherapy involving cisplatin. Lobectomy or Pneumectomy
• Chemotherapy
• Radiation therapy (radiotherapy)
• Laser therapy
• Radiosurgery (SRS) or targeted therapy. As a class, NSCLCs are relatively insensitive to chemotherapy
• more treatments...»

Non-Small Cell Lung Cancer Treatment: Book Excerpts

• Treatment - Malignant spinal neoplasms
• Treatment - Lung cancer
• Treatment - Lung cancer

Evidence Based Medicine Research for Non-Small Cell Lung Cancer

Medical research papers related to Non-Small Cell Lung Cancer include:

• Postoperative radiotherapy for non-small cell lung cancer
• Pemetrexed (Alimta) - In combination with cisplatin for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC)
• Palliative endobronchial brachytherapy for non-small cell lung cancer
• Pemetrexed (Alimta) - Non-small cell lung cancer - maintenance therapy after first-line induction chemotherapy
• Pemetrexed (Alimta) - monotherapy for second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology
• Pemetrexed (Alimta) - As a monotherapy for treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) after prior chemotherapy
• Erlotinib for the treatment of non-small cell lung cancer
• Chemotherapy and surgery versus surgery alone in non-small cell lung cancer
• Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease
• Sorafenib (BAY 43-9006) Non-small cell lung cancer ? advanced
• Vandetanib (Zactima, -6474, AZD-6474, ZD6474) Non-small cell lung cancer ? locally advanced or metastatic, second line therapy
• Pemetrexed (Alimta) - Locally advanced or metastatic non-small cell lung cancer
• The noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines. (2nd Edition)
• Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines. (2nd Edition)
• Treatment of non-small cell lung cancer, stage IIIB: ACCP evidence-based clinical practice guidelines. (2nd Edition)
• Treatment of non-small cell lung cancer, stage IV: ACCP evidence-based clinical practice guidelines. (2nd Edition)
• Comparative cost-minimisation of oral and intravenous chemotherapy for first-line treatment of non-small cell lung cancer in the UK NHS system
• Endoscopic ultrasound-guided fine-needle aspiration for non-small cell lung cancer staging: a systematic review and metaanalysis
• Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of systematic review.
• Bevacizumab (Avastin) - non-small cell lung cancer
• Erlotinib (Tarceva) Non-small cell lung cancer ? locally advanced or metastatic (in combination with bevacizumab) second-line and maintenance therapy
• Endoscopic Ultrasound-Guided Fine-Needle Aspiration for Non-small Cell Lung Cancer Staging: A Systematic Review and Metaanalysis.
• Cost-effectiveness analysis of amifostine (Ethyol) in patients with non-small cell lung cancer
• Non-small cell lung cancer
• Lung cancer (Localised disease) - Chemotherapy (adjuvant/neoadjuvant) for NSCLC
• Lung cancer (Advanced disease) - Radiotherapy for NSCLC
• Lung cancer (Localised disease) - Surgery for NSCLC
• Lung cancer (Advanced disease) - Biological agents for NSCLC
• Lung cancer (Localised disease) - Radiotherapy for NSCLC
• Pemetrexed (Alimta) Non small cell lung cancer ? first line, locally advanced or metastatic

Click here to find more evidence-based articles on the TRIP Database

 » Next page: Medical News Summaries About Non-Small Cell Lung Cancer

Rate This Website

What do you think about the features of this website? Take our user survey and have your say:

Website User Survey

Medical Tools & Articles:

Next articles:

• Medical News Summaries About Non-Small Cell Lung Cancer
• Hospital Statistics for Non-Small Cell Lung Cancer
• Articles about Non-Small Cell Lung Cancer
• Glossary for Non-Small Cell Lung Cancer
• Introduction: Malignant Neoplasms (Professional Guide to Diseases (Eighth Edition))

Tools & Services:

• Bookmark this page
• Symptom Search
• Symptom Checker
• Medical Dictionary
• Give your feedback

Medical Articles:

• Disease & Treatments Search
• Misdiagnosis Center
• Full list of interesting articles

Forums & Message Boards

• Ask or answer a question at the Boards:
• I cannot get a diagnosis. Please help.
• Tell us your medical story.
• Share your misdiagnosis story.
• What is the best treatment for my condition?
• See all the Boards.

Enter your search terms Submit search form
Search The Web Search wrongdiagnosis.com

Common Health Mistakes

Symptom
Checker

Search Specialists by State and City